MapLight Therapeutics, Inc. MPLT
6.93 USD +0.71 (+11.41%)
At closeNov 6, 2026, 7:35 PM EST
7.60 +0.67 +9.67%
After hours · Nov 6, 7:35 PM ET
6.06 Day range 6.93
6.22 52-week range 39.80
- YTD
- -60.56%
- 1 year
- -57.06%
Financial health
Altman Z-Score
5.90 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -4.8×
FY 2022 5y median -11.7× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 1.7×
FY 2022 5y median 8.6× FY 2025
P/FCF -5.6×
FY 2022 5y median -12.0× FY 2025
EV/EBITDA -4.6×
FY 2022 5y median -11.0× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -17.9%
FY 2022 5y median -8.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -35.2%
FY 2022 5y median -72.7% FY 2025
ROIC -36.4%
FY 2022 5y median -71.2% FY 2025
ROA -33.6%
FY 2022 5y median -58.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -103.8%
FY 2022 FY 2025
EPS (diluted) -95.7%
FY 2022 FY 2025
Free Cash Flow -74.2%
FY 2022 FY 2025
Financial Health
Current Ratio 20.0×
FY 2022 5y median 6.4× FY 2025
Quick Ratio 20.0×
FY 2022 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2022 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31